People · Operator
Named in public records as an officer, director or promoter · active 2022–2023 · Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Violet Therapeutics, Inc. | — | Pharma | Series A | $7.4M | $65.7M | 2023 |
| FireCyte Therapeutics, Inc. | — | Pharma | Series A | $5.5M | $85.5M | 2022 |
William E Yelle at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside William E Yelle on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Meredith Fisher | 1 | 6 |
| Jonathan Behr | 1 | 4 |
| Atsushi Usami | 1 | 3 |
| Meredith E Fisher | 1 | 1 |
| Ruoxi E Hu | 1 | 1 |
| Charles E Kunsch | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.